Brenda Jenkins

Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity

David Ginsberg, Angelo E. Gousse, V. Keppenne et al. · The Journal of Urology · 2012 · 350 citations

Medicine, Pharmacotherapy, Urology +17

Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures.

Emmanuel Keku, Wayne D. Rosamond, Herman A. Taylor et al. · PubMed · 2005 · 133 citations

Medicine, Cardiology, Clinical Sciences +10

Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study

Victor W. Νitti, David Ginsberg, Karl‐Dietrich Sievert et al. · The Journal of Urology · 2016 · 121 citations

Medicine, Pharmacology, Pharmacotherapy +16

OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology

David A. Ginsberg, Francisco Cruz, Sender Herschorn et al. · Advances in Therapy · 2013 · 84 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long‐term extension study

Michael Kennelly, Roger R. Dmochowski, Heinrich Schulte‐Baukloh et al. · Neurourology and Urodynamics · 2015 · 80 citations · Full text

Medicine, Pharmacotherapy, Urology +17